Company: LENZ
Filing Date: 2025-04-15
Form Type: 8-K
Source: 0001815776-25-000025
Chunk: 1

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-15
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure.

As previously announced, the Company is hosting a Commercial Day today, Tuesday, April 15, 2025, at 2:00 p. m. Eastern time. The event will include presentations by management to feature key updates as the Company approaches the potential approval and launch of LNZ100, including commercialization strategies, supply chain and product distribution readiness and perspectives from Key Opinion Leaders and Eye Care Professionals. A live audio webcast of the presentation will be available through a link on the Events section of the Investor Relations page of the Company’s website at www. LENZ-tx. com. During the Commercial Day presentation, the Company will present an updated slide presentation, which will be available on the Investor Relations page on the Company’s website at www. LENZ-tx. com. The information available on the Company’s website, including the updated corporate presentation, is not incorporated by reference herein, and the inclusion of the Company’s website address is an inactive textual reference only.

The information contained in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 8.01 Other Events.